Detalhe da pesquisa
1.
A combination of cyclophosphamide and interleukin-2 allows CD4+ T cells converted to Tregs to control scurfy syndrome.
Blood;
137(17): 2326-2336, 2021 04 29.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33545713
2.
A gain-of-function RAC2 mutation is associated with bone-marrow hypoplasia and an autosomal dominant form of severe combined immunodeficiency.
Haematologica;
106(2): 404-411, 2021 02 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31919089
3.
A Recurrent De Novo Nonsense Variant in ZSWIM6 Results in Severe Intellectual Disability without Frontonasal or Limb Malformations.
Am J Hum Genet;
101(6): 995-1005, 2017 Dec 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29198722
4.
Therapeutic effect of JAK1/2 blockade on the manifestations of hemophagocytic lymphohistiocytosis in mice.
Blood;
128(1): 60-71, 2016 07 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27222478
5.
Polygenic mutations in the cytotoxicity pathway increase susceptibility to develop HLH immunopathology in mice.
Blood;
127(17): 2113-21, 2016 04 28.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26864340
6.
A novel immunoregulatory role for NK-cell cytotoxicity in protection from HLH-like immunopathology in mice.
Blood;
125(9): 1427-34, 2015 Feb 26.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25525117
7.
Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1.
J Clin Invest;
118(9): 3132-42, 2008 Sep.
Artigo
em Inglês
| MEDLINE
| ID: mdl-18688285
8.
Cytokines and culture medium have a major impact on human in vitro T-cell differentiation.
Blood Cells Mol Dis;
47(1): 72-8, 2011 Jun 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-21531153
9.
Vector integration is nonrandom and clustered and influences the fate of lymphopoiesis in SCID-X1 gene therapy.
J Clin Invest;
117(8): 2225-32, 2007 Aug.
Artigo
em Inglês
| MEDLINE
| ID: mdl-17671652
10.
DNA bar coding and pyrosequencing to analyze adverse events in therapeutic gene transfer.
Nucleic Acids Res;
36(9): e49, 2008 May.
Artigo
em Inglês
| MEDLINE
| ID: mdl-18411205
11.
Stable and functional lymphoid reconstitution in artemis-deficient mice following lentiviral artemis gene transfer into hematopoietic stem cells.
Mol Ther;
16(8): 1490-9, 2008 Aug.
Artigo
em Inglês
| MEDLINE
| ID: mdl-18560421
12.
Author Correction: Germline HAVCR2 mutations altering TIM-3 characterize subcutaneous panniculitis-like T cell lymphomas with hemophagocytic lymphohistiocytic syndrome.
Nat Genet;
51(1): 196, 2019 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30429576
13.
Germline HAVCR2 mutations altering TIM-3 characterize subcutaneous panniculitis-like T cell lymphomas with hemophagocytic lymphohistiocytic syndrome.
Nat Genet;
50(12): 1650-1657, 2018 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30374066
14.
[Gene therapy of severe combined immunodeficiency disease: proof of principle of efficiency and safety issues. Gene therapy, primary immunodeficiencies, retrovirus, lentivirus, genome]. / Thérapie génique des déficits immunitaires sévères: preuve de principe d'efficacité et problèmes soulevés. Thérapie génique, déficits immunitaires, rétrovirus, lentivirus, génome.
Bull Acad Natl Med;
189(5): 779-85; discussion 786-8, 2005 May.
Artigo
em Francês
| MEDLINE
| ID: mdl-16433450
15.
Mutating RBF can enhance its pro-apoptotic activity and uncovers a new role in tissue homeostasis.
PLoS One;
9(8): e102902, 2014.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25089524
16.
A human postnatal lymphoid progenitor capable of circulating and seeding the thymus.
J Exp Med;
204(13): 3085-93, 2007 Dec 24.
Artigo
em Inglês
| MEDLINE
| ID: mdl-18070935
17.
Real-time definition of non-randomness in the distribution of genomic events.
PLoS One;
2(6): e570, 2007 Jun 27.
Artigo
em Inglês
| MEDLINE
| ID: mdl-17593969
18.
Long-term immune reconstitution in RAG-1-deficient mice treated by retroviral gene therapy: a balance between efficiency and toxicity.
Blood;
107(1): 63-72, 2006 Jan 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-16174758
19.
Clonal evidence for the transduction of CD34+ cells with lymphomyeloid differentiation potential and self-renewal capacity in the SCID-X1 gene therapy trial.
Blood;
105(7): 2699-706, 2005 Apr 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-15585650